Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, November 17, 2022

The global impact of stroke in 2022

It's plain as day the WSO has no intention of solving stroke to 100% recovery. They've reached for the bottom of the barrel in just raising awareness. They need to be destroyed and run by survivors.

You'll have to tell your children and grandchildren to never have a stroke since they are effectively untreatable(True treatment is 100% recovery, NOTHING LESS), contrary to this lie from World Stroke Day a few years ago. 

What a lying piece of shit.

 



 


 

The global impact of stroke in 2022


  • PDF / ePub
  • Free access



  • Restricted access
    Each year, the November issue of the International Journal of Stroke (IJS) coincides with World Stroke Day, which this year is on Saturday 29 October. World Stroke Day is coordinated by the World Stroke Organization (WSO) and is an opportunity for us all to highlight the enormous global burden of stroke and to promote campaigns to reduce its incidence and impact. In this month’s issue, to coincide with World Stroke Day 2022, we publish the important Global Stroke Statistics 2022.1 This initiative regularly reviews stroke incidence, case-fatality, and mortality across the world. It provides key data for health providers, clinicians, and researchers. Once again, it demonstrates evidence of major global disparities in stroke incidence and mortality, with a particular burden in low- and middle-income countries (LMICs). A shorter summary of key stroke facts is also is available in our 2022 global stroke factsheet.2
    In view of the lack of high-quality epidemiological data from many regions worldwide, as highlighted by the Global Stroke Statistics paper, we are particularly pleased to also publish in this issue a population-based study on stroke incidence from the Qom area in central Iran.3 This shows a high incidence of stroke, with an age of onset earlier than the global average. Epidemiological data also provide the opportunity to identify trends in stroke incidence in specific regions, and in particular whether health interventions and better control of risk factors are reducing incidence. A further paper in this month’s issue analyzed the incidence and mortality of cerebrovascular disease in Spain from 2001 to 2015.4 Reassuringly, it was found that stroke mortality reduced by half in Spain over this period, consistent with many studies from other high-income countries.5 These show that a combination of public health measures, and better primary prevention, can reduce incidence of stroke and cardiovascular disease and emphasises the importance of developing such approaches globally, including in LMIC.
    An important step to improving care in LMIC is documenting the current state of stroke services. This is addressed by a collaborative paper from authors across Africa, also in this month’s issue.6 The authors highlight how stroke used to be viewed as a rare disease in Africa, but that it is now considered one of the common noncommunicable diseases with a reported annual incidence in some African countries ranging from 250 to 316 per 100,000, and prevalence rates of 560 to 1460 per 100,000.6 Moreover, stroke has become one of the leading causes of morbidity and mortality, with a 3-year fatality rate as high as 84%. Despite this heavy burden, the results of the survey reveal an inadequacy of well-structured primary stroke prevention and public awareness programs in many African countries. Similarly, acute stroke management is inadequate, with only five stroke units and two centers among the 17 studied countries, and a low percentage of recanalization therapy, whether thrombolysis or thrombectomy, being provided in less than 5% of all acute cases. In addition, thrombectomy is available only in 35% of the participating countries.
    A major emerging factor in stroke risk worldwide is air pollution. Increasing studies suggest air quality is an important determinant of cardiovascular health, including both ischaemic heart disease and stroke.79 Further evidence of this association is provided in a paper by Ho et al. in this issue.10 They performed a nationwide population-based analysis of all ischaemic stroke cases reported to the Singapore Stroke Registry between 2009 and 2018. Using this, they estimated the incidence rate ratio of ischaemic stroke across different concentrations of different pollutants. Ozone and carbon monoxide were positively associated with ischaemic stroke incidence, and this increased risk persisted for 5 days after exposure. Interestingly, individuals with atrial fibrillation were more susceptible to exposure from pollutants. This, and other data, emphasises the importance of public health measures to improve air quality worldwide.
    Cardiovascular risk factors also play an important role in stroke risk. A study by Joundi et al. using the Canadian Community Health Survey, looked at the contribution of four common risk factors (diabetes, hypertension, obesity, and diabetes) to stroke risk across different age ranges.11 Almost 500,000 people were included in an analysis, with 8865 stroke events. Associations of diabetes, hypertension, and obesity with stroke risk were stronger at younger age and progressively reduced with increasing age. These data emphasise the importance of attending to cardiovascular risk in early life, rather than waiting until middle or late age. The authors suggest it also provides important information to address stroke risk in the young which is not decreasing in high-income countries in the same way in which we are seeing reductions in overall stroke incidence.
    One test we sometimes ask for in cryptogenic stroke is syphilis. However, how important syphilis really is in stroke risk, particularly with the more widespread use of antibiotics, remains unclear. To to answer this question Chang et al. from Taiwan conducted a long-term population-based study to determine the risk of new ischaemic stroke after syphilis infection.12 In 1585 patients with syphilis, 3.8% developed new onset ischaemic stroke, and compared to controls syphilis was associated with a higher risk of ischaemic stroke with a hazard ratio of 1.35 (1.01–1.80).
    We are delighted to include the latest Japanese Stroke Guidelines in this issue.13 These important guidelines are published in full in Japanese but a summary of the important recommendations are presented in an English version in this issue.
    Finally release of this issue is coinciding with the Word Stroke Congress, the WSO’s now annual conference, between October 26th and 29th in Singapore. It’s a very exciting program, and we hope to see many of you there. (https://worldstrokecongress.org). All delegates will have free access to this issue of the IJS.
    Hugh S Markus
    University of Cambridge
    Email: hsm32@medschl.cam.ac.uk

    No comments:

    Post a Comment